Published October 3, 2024
Cellevate to pre-launch first nanofiber microcarriers for boosting viral vector production in gene therapy applications at CPHI Milan
LUND, Sweden – Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, is ready to pre-launch the world’s 1st nanofiber microcarrier for gene therapy at CPHI Milan, October 8-10, 2024. By providing up to 60 times more surface area for cell growth than conventional systems, Cellevat3d® nanofiber microcarriers increase yield and…
Published September 16, 2024
Cellevate closes second seed round, raising 3.2 MEUR to enter into global commercialization
LUND, Sweden – Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, announced today the successful closure of its recent second seed round led by Industrifonden in syndication with the European Innovation Council Fund (EIC Fund), securing a total of 3.2 MEUR. By achieving commercial and technical readiness in Q3 2024,…
Published September 6, 2024
Cellevate appoints bioprocessing industry expert Bettina Berendsen as Board Observer and Strategic Advisor
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems based on nanotechnology, is pleased to announce the appointment of Bettina Berendsen as Board of Directors Observer as well as Strategic Advisor. Bettina Berendsen is an executive leader with over 35 years of extensive experience in the global…
Published June 5, 2024
Cellevate appoints bioprocessing expert Dr. Christel Fenge as Strategic Advisor
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, is pleased to announce the appointment of Dr. Christel Fenge as Strategic Advisor. Dr. Fenge brings over 30 years of experience in various leadership roles across the bioprocessing and biopharmaceutical industry. Dr. Fenge previously…
Published March 15, 2024
Cellevate announces poster presentation at Advanced Therapies in London, UK, on March 19-20, 2024
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces a poster presentation at the Advanced Therapies congress in London on March 19-20, 2024. In the poster, we present positive results on the use of the 1st nanofiber-based microcarriers, Cellevat3dTM microcarriers, in…
Published March 14, 2024
Cellevate announces the appointment of renowned industrial biotechnology and bioprocessing expert Dr. Uwe Gottschalk as new Chairman of the Board of Directors
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, announces that Dr. Uwe Gottschalk has been elected as Chairman to its Board of Directors. The appointment follows the resignation of Mats Leifland, who served as Chairman of the Board until March 12, 2024….
Published March 14, 2024
Cellevate tillkännager utnämningen av Dr. Uwe Gottschalk, välkänd expert inom industriell bioteknik och bioprocesser, till ny styrelseordförande
LUND, Sverige – Cellevate AB, ett innovativt bioteknikföretag som utvecklar nästa generations cellodlingssystem designat för att revolutionera bioproduktion, meddelar att Dr. Uwe Gottschalk har valts till styrelseordförande. Dr. Gottschalk efterträder därmed Mats Leifland, som var styrelseordförande fram till den 12 mars 2024. Dr. Gottschalk bidrar med omfattande erfarenheter inom bioteknikområdet och har en framstående karriär…
Published December 18, 2023
Inauguration of Cellevate’s new upstream bioprocessing cell culture laboratory at Medicon Village in Lund
LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, celebrated last week the inauguration of its new, larger premises at Medicon Village in Lund, Sweden. The highlight of the event was the official opening of the internal upstream bioprocessing cell culture facility,…
Published December 4, 2023
Cellevate progresses to second half of the European Innovation Council Accelerator project focused on scaling up for the commercialization of Cellevat3d™ microcarriers in bioprocessing applications
LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, has successfully received the European Innovation Council (EIC) Accelerator project half time progress approval. The project which started in October 2022, is dedicated to develop and scale up the company for the large-scale…
Published October 10, 2023
Cellevate raises 39 million SEK in Seed Financing to accelerate their global commercial launch
LUND, Sweden – Cellevate, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, announced today the successful closure of its recent investment round, securing a total of 39 million SEK. The round was led by Industrifonden, in syndication with the European Innovation Council Fund (EIC Fund) and…
